How to take Citidaron: A Short Video
Resources
Here you’ll find helpful tools and information to guide you through your treatment.
- Citidaron Summary of Product Characteristics (SmPC) (Accessed: October, 2025)
- Citidaron Patient Information Leaflet (PIL) (Accessed: October, 2025)
IE-CH-1485(2) DOP: October 2025
Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional. Please consult your doctor or nurse for further information.
If you get any side effects from a Consilient Health pharmaceutical product, please talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed on the label. You can also report side effects directly to HPRA Pharmacovigilance via www.hpra.ie. By reporting side effects, you can help provide information on the safety of this medicine or medical device.
The information on this website is intended for patients who have been prescribed Citidaron who reside in the Republic of Ireland only.